Complications of Intravitreal Ocriplasmin in the Treatment of Symptomatic Vitreomacular Adhesion

被引：0
|
作者：
Feng, Henry L. [1 ]
Roth, Daniel B. [1 ]
Modi, Kunjal K. [1 ]
Fine, Howard F. [1 ]
Wheatley, Harold M. [1 ]
机构：
[1] Robert Wood Johnson Med Sch, Piscataway, NJ USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
763; vitreous; 688; retina; 561; injection;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
308
引用
收藏
页数：2
相关论文
共 50 条
  • [31] SAFETY PROFILE OF OCRIPLASMIN FOR SYMPTOMATIC VITREOMACULAR ADHESION A Comprehensive Analysis of Premarketing and Postmarketing Experiences
    Hahn, Paul
    Chung, Mina M.
    Flynn, Harry W., Jr.
    Huang, Suber S.
    Kim, Judy E.
    Mahmoud, Tamer H.
    Sadda, Srinivas R.
    Dugel, Pravin U.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (06): : 1128 - 1134
  • [32] Incomplete Vitreomacular Traction Release Using Intravitreal Ocriplasmin
    Chin, Eric K.
    Almeida, David R. P.
    Sohn, Elliott H.
    Boldt, H. Culver
    Mahajan, Vinit B.
    Gehrs, Karen M.
    Russell, Stephen R.
    Folk, James C.
    CASE REPORTS IN OPHTHALMOLOGY, 2014, 5 (03): : 455 - 462
  • [33] Vitreomacular traction quantitative cutoffs for the assessment of resolution after ocriplasmin intravitreal treatment
    Arrigo, Alessandro
    Calamuneri, Alessandro
    Bordato, Alessandro
    Aragona, Emanuela
    Pierro, Luisa
    Bandello, Francesco
    Parodi, Maurizio Battaglia
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [34] Incomplete Release of Vitreomacular Attachments After Intravitreal Ocriplasmin
    Jeng, Karen W.
    Baumal, Caroline R.
    Witkin, Andre J.
    Witkin, Steve R.
    Wiegand, Torsten W.
    Waheed, Nadia K.
    Ophthalmic Surgery Lasers & Imaging Retina, 2015, 46 (02): : 271 - 274
  • [35] Vitreomacular traction quantitative cutoffs for the assessment of resolution after ocriplasmin intravitreal treatment
    Alessandro Arrigo
    Alessandro Calamuneri
    Alessandro Bordato
    Emanuela Aragona
    Luisa Pierro
    Francesco Bandello
    Maurizio Battaglia Parodi
    Scientific Reports, 10
  • [36] Ocriplasmin in the treatment of vitreomacular traction - for
    Xirou, T.
    Chatziralli, I.
    ACTA OPHTHALMOLOGICA, 2017, 95
  • [37] Ocriplasmin for Vitreomacular Adhesion: Aftermarket Experience and Findings
    Nudleman, Eric
    Ruby, Alan J.
    Wolfe, Jeremy
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [38] Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome
    Singh, Rishi P.
    Li, Ang
    Bedi, Rumneek
    Srivastava, Sunil
    Sears, Jonathan E.
    Ehlers, Justis P.
    Schachat, Andrew P.
    Kaiser, Peter K.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (03) : 356 - 360
  • [39] Clinical Results of Ocriplasmin For Symptomatic Vitreomacular Traction Syndrome
    Chawla, Anuj
    Fortun, Jorge
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [40] OASIS: A 2-Year Study Evaluating Ocriplasmin for the Treatment of Symptomatic Vitreomacular Adhesion/Vitreomacular Traction Including Full-Thickness Macular Hole
    Dugel, Pravin
    OPHTHALMOLOGICA, 2016, 236 : 31 - 32
12345